Update on the treatment of tics.
Lang
A E
AE
Movement Disorders Centre, Toronto Western Hospital Division of University Health Network and University of Toronto, Toronto, Ontario, Canada.
D018726:Anti-Dyskinesia Agents / Q000627:therapeutic use*; D001289:Attention Deficit Disorder with Hyperactivity / Q000150:complications / Q000188:drug therapy / Q000601:surgery; D001905:Botulinum Toxins / Q000627:therapeutic use*; D018678:Cholinergic Agents / Q000627:therapeutic use; D015259:Dopamine Agents / Q000627:therapeutic use; D006801:Humans; D009771:Obsessive-Compulsive Disorder / Q000150:complications / Q000188:drug therapy / Q000601:surgery; D020323:Tics / Q000150:complications / Q000188:drug therapy* / Q000601:surgery
D018726:Anti-Dyskinesia Agents; D018678:Cholinergic Agents; D015259:Dopamine Agents; D001905:Botulinum Toxins